Rhoen Klinikum AG (ETR:RHK) has been assigned a consensus rating of “Sell” from the seven analysts that are currently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is €21.96 ($25.53).
A number of research analysts have weighed in on the company. Independent Research set a €25.50 ($29.65) price target on Rhoen Klinikum and gave the company a “neutral” rating in a research note on Monday, August 5th. Berenberg Bank set a €26.20 ($30.47) price target on Rhoen Klinikum and gave the company a “neutral” rating in a research note on Tuesday, July 30th. Finally, Credit Suisse Group set a €16.50 ($19.19) price target on Rhoen Klinikum and gave the company a “sell” rating in a research note on Monday, August 5th.
RHK stock opened at €21.80 ($25.35) on Tuesday. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 9.80. The business has a 50 day moving average price of €22.98 and a two-hundred day moving average price of €24.95. The company has a market cap of $1.46 billion and a price-to-earnings ratio of 28.17. Rhoen Klinikum has a twelve month low of €21.06 ($24.49) and a twelve month high of €27.40 ($31.86).
About Rhoen Klinikum
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.
Further Reading: What does the Producer Price Index (PPI) tell investors?
Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.